Results 151 to 160 of about 29,491 (205)
Personalized prediction model for scar response after radionuclide therapy: development and validation in a Chinese cohort. [PDF]
Su J +6 more
europepmc +1 more source
Chelator Optimization and Therapeutic Potential of <sup>188</sup>Re-FAPI for FAP-Targeted Radionuclide Therapy. [PDF]
Liang SH.
europepmc +1 more source
Effects of Targeted Radionuclide Therapy on Cancer Cells Beyond the Ablative Radiation Dose. [PDF]
Ferro-Flores G +5 more
europepmc +1 more source
Navigating care: understanding cancer patients' experiences with systemic radionuclide therapy. [PDF]
Starkbaum J +3 more
europepmc +1 more source
Peptide receptor radionuclide therapy in G3 gastroenteropancreatic neuroendocrine tumors: a missed opportunity for European patients? [PDF]
Panzuto F, Cives M, Strosberg J.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
2022
The main purpose of this book is to create a reference for the indications, contraindications, patient selection, treatment practice, treatment side effect management, and follow-up of radionuclide treatments.Besides standard methods such as surgery, chemotherapy, radiotherapy, and hormone therapy, newly developed biological treatments, targeted ...
POLACK, BERNA +2 more
+13 more sources
The main purpose of this book is to create a reference for the indications, contraindications, patient selection, treatment practice, treatment side effect management, and follow-up of radionuclide treatments.Besides standard methods such as surgery, chemotherapy, radiotherapy, and hormone therapy, newly developed biological treatments, targeted ...
POLACK, BERNA +2 more
+13 more sources
Clinical Oncology, 1999
Nuclear medicine therapy uses unsealed radioactive sources for the selective delivery of radiation to tumours or target organs. For benign disorders such as thyrotoxicosis and arthritis radionuclide therapy provides an alternative to surgery or medical treatment.
R B, Buchanan, V J, Lewington
openaire +5 more sources
Nuclear medicine therapy uses unsealed radioactive sources for the selective delivery of radiation to tumours or target organs. For benign disorders such as thyrotoxicosis and arthritis radionuclide therapy provides an alternative to surgery or medical treatment.
R B, Buchanan, V J, Lewington
openaire +5 more sources
Radionuclide therapy of the thyroid
European Journal of Nuclear Medicine, 1991Radionuclide therapy has a proven place in the management of patients with thyroid disease. Iodine-131 therapy has been established as both successful and safe in treating patients with thyrotoxicosis and thyroid malignancy. Protocols for patient treatment are now standardised, although some variation in practice exists across Europe.
openaire +2 more sources
Radionuclide therapy revisited
European Journal of Nuclear Medicine, 1991Apart from its use in endocrinology and rheumatology, therapeutic nuclear medicine is developing rapidly as an additional treatment modality in oncology. Many different specific tumour-seeking radiopharmaceuticals are being applied both for diagnostic scintigraphy and treatment, using multiple routes and mechanisms to target radionuclides at tumours ...
openaire +2 more sources
Annals of Nuclear Medicine, 1998
Therapeutic nuclear medicine is rapidly developing as an additional treatment modality in oncology. Its unique characteristics are the systemic, yet selective delivery of radiation doses in target tissues, its non-invasiveness, the relative lack of immediate and late side effects, and the advantage that uptake and retention in the tumor can be pre ...
openaire +2 more sources
Therapeutic nuclear medicine is rapidly developing as an additional treatment modality in oncology. Its unique characteristics are the systemic, yet selective delivery of radiation doses in target tissues, its non-invasiveness, the relative lack of immediate and late side effects, and the advantage that uptake and retention in the tumor can be pre ...
openaire +2 more sources

